Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

BIO-TECHNE (TECH) EBT Margin: 2009-2025

Historic EBT Margin for BIO-TECHNE (TECH) over the last 16 years, with Sep 2025 value amounting to 16.75%.

  • BIO-TECHNE's EBT Margin rose 287.00% to 16.75% in Q3 2025 from the same period last year, while for Sep 2025 it was 8.74%, marking a year-over-year decrease of 631.00%. This contributed to the annual value of 8.07% for FY2025, which is 795.00% down from last year.
  • Per BIO-TECHNE's latest filing, its EBT Margin stood at 16.75% for Q3 2025, which was up 332.22% from -7.21% recorded in Q2 2025.
  • In the past 5 years, BIO-TECHNE's EBT Margin registered a high of 5,185.80% during Q3 2022, and its lowest value of -7.21% during Q2 2025.
  • Moreover, its 3-year median value for EBT Margin was 14.43% (2024), whereas its average is 15.49%.
  • Per our database at Business Quant, BIO-TECHNE's EBT Margin spiked by 515,965bps in 2022 and then slumped by 516,790bps in 2023.
  • BIO-TECHNE's EBT Margin (Quarterly) stood at 32.00% in 2021, then plummeted by 754bps to 24.46% in 2022, then plummeted by 1,221bps to 12.25% in 2023, then spiked by 219bps to 14.43% in 2024, then surged by 287bps to 16.75% in 2025.
  • Its EBT Margin stands at 16.75% for Q3 2025, versus -7.21% for Q2 2025 and 12.11% for Q1 2025.